Evidence map›Paper›PMID 34745608›Full record

ArticleTherapeutic advances in infectious disease

COVID-19 vaccine hesitancy among staff and students in a Nigerian tertiary educational institution.

Ikemefuna Chijioke Uzochukwu, George Uchenna Eleje, Chike Henry Nwankwo, George Okechukwu Chukwuma, Chinwendu Alice Uzuke, Chinwe Elizabeth Uzochukwu, Bentina Alawari Mathias, Chinyere Stella Okunna, Lasbrey Azuoma Asomugha, Charles Okechukwu Esimone

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ikemefuna Chijioke UzochukwuDepartment of Pharmaceutical & Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka 420281, Nigeria.ORCID https://orcid.org/0000-0002-5139-1537
George Uchenna ElejeDepartment of Obstetrics and Gynecology, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria.ORCID https://orcid.org/0000-0002-0390-2152
Chike Henry NwankwoDepartment of Statistics, Faculty of Physical Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
George Okechukwu ChukwumaDepartment of Medical Laboratory Science, Faculty of Health Sciences and Technology, Nnamdi Azikiwe University, Awka, Nigeria.ORCID https://orcid.org/0000-0002-7397-2391
Chinwendu Alice UzukeDepartment of Statistics, Faculty of Physical Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
Chinwe Elizabeth UzochukwuDepartment of Mass Communication, Faculty of Social Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
Bentina Alawari MathiasDepartment of Sociology and Anthropology, Faculty of Social Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
Chinyere Stella OkunnaDepartment of Mass Communication, Faculty of Social Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
Lasbrey Azuoma AsomughaDepartment of Anatomy, Faculty of Basic Medical Sciences/University Medical Services, Nnamdi Azikiwe University, Awka, Nigeria.
Charles Okechukwu EsimoneDepartment of Pharmaceutical Microbiology & Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
Nnamdi Azikiwe University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 was first reported on 31 December 2019 and has so far claimed over 2,000 lives in Nigeria. Through global and national efforts, about 4 million doses of the AstraZeneca vaccine was distributed and used in Nigeria from March 2021. Vaccine hesitancy could pose a serious problem for COVID-19 prevention and control.

objectivesTo estimate the proportion of the Nnamdi Azikiwe University community that is willing to be vaccinated against COVID-19; level of hesitancy and its associated factors.

methodsA cross-sectional survey was conducted using online Google form distributed to staff and students of the university via different WhatsApp groups. The outcome measures were the proportion of persons willing to be vaccinated, vaccine hesitancy rates and reasons for this hesitancy. Data were analyzed using SPSS version 23 and Minitab version 19. Bivariate analysis was performed by the chi-square test, Odds Ratios (ORs) and statistical significance was accepted when

resultsOnly 349 of the survey responses were analyzed in the survey. Results show that 34.70 ± 5.00% of the university community were willing to receive the COVID-19 vaccine when it is offered to them. The COVID-19 hesitancy rate among staff and students was 65.04 ± 5.00%. It was discovered that marital status (OR = 2.06), age (OR = 0.802) and christian denominational affiliation (OR = 0.366) influenced respondents' perception of COVID-19 vaccination. Gender, occupation, previous vaccination experience, awareness of COVID-19 and previous symptoms of COVID-19 did not significantly (

conclusionCOVID-19 vaccine hesitancy is high among staff and students in a Nigerian university and is significantly influenced by marital status, respondents' age and christian denominational affiliation.

Indexed as

AstraZenecaCOVID-19NigeriaNnamdi Azikiwe Universityvaccine hesitancy

Identifiers

PMID34745608
PMCPMC8564127
OpenAlexW3211268517

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.